Detalhe da pesquisa
1.
Engineered AAV8 capsid acquires heparin and AVB sepharose binding capacity but has altered in vivo transduction efficiency.
Gene Ther
; 30(3-4): 236-244, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33028973